Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Rare Disease Therapies
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 01.03.15 |
Founder | 64 | 10.07.15 | |
Charles Sermon
FOU | Founder | 55 | 01.03.15 |
Christine Fox
DFI | Director of Finance/CFO | 43 | 31.01.21 |
Michael Wyzga
CHM | Chairman | 69 | 23.04.19 |
Suba Krishnan
CTO | Chief Tech/Sci/R&D Officer | 59 | 07.12.20 |
John Lewicki
CTO | Chief Tech/Sci/R&D Officer | 72 | 01.07.20 |
Richard Francis
PRN | Corporate Officer/Principal | - | 01.08.19 |
Corporate Officer/Principal | 53 | 01.03.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 23.04.19 |
Marc Yoskowitz
BRD | Director/Board Member | 49 | 10.11.22 |
Director/Board Member | 59 | 23.04.19 | |
Founder | 64 | 10.07.15 | |
Director/Board Member | 70 | 01.07.15 | |
Pierre Jacquet
BRD | Director/Board Member | 57 | 20.09.21 |
Justin Roberts
BRD | Director/Board Member | 42 | 10.11.22 |
Annalisa Jenkins
BRD | Director/Board Member | 58 | 10.11.22 |
Jeremy Bender
BRD | Director/Board Member | 52 | 01.10.20 |
Daniel Shames
BRD | Director/Board Member | 78 | 10.11.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 701 217 089 | 301 926 833 ( 43,06 %) | 0 | 43,06 % |
Unternehmenskontakt
Mereo BioPharma Group Plc
1 Cavendish Place 4th Floor
W1G 0QF, London
+44 33 3023 7300
http://www.mereobiopharma.com![Straße Mereo BioPharma Group PLC](https://cdn.zonebourse.com/static/address/28607946.png)
Sektor
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+21.45% | 127 Mrd. | |
+24.35% | 117 Mrd. | |
+25.44% | 27.67 Mrd. | |
-18.80% | 20.33 Mrd. | |
-15.17% | 16.79 Mrd. | |
-16.12% | 15.63 Mrd. | |
+12.83% | 14.84 Mrd. | |
-47.10% | 14.65 Mrd. | |
+57.89% | 14.43 Mrd. |